Elevated PLMI During CPAP Titration Study
An elevated periodic limb movement index (PLMI) during CPAP titration most commonly represents "unmasking" of underlying periodic limb movement disorder (PLMD) or restless legs syndrome (RLS) that was previously suppressed by severe obstructive sleep apnea. 1
Primary Mechanism: Unmasking of Underlying Sleep Disorder
The most well-established cause is the unmasking phenomenon where severe OSA masks concurrent PLMD/RLS, which becomes evident once CPAP effectively treats the apnea 2, 3. This occurs because:
- Severe OSA disrupts sleep architecture so profoundly that periodic limb movements cannot manifest their typical pattern
- Once CPAP restores normal breathing and sleep continuity, the underlying movement disorder emerges
- This is particularly common in patients with higher baseline apnea-hypopnea index (AHI) 4, 5
Key Clinical Predictors of Unmasking:
- Older age (≥47 years) 4, 5
- Severe OSA (higher baseline AHI, particularly >74 events/hour) 2, 4
- Higher CPAP pressures required (>8.2 cm H₂O) 2
- Low or absent PLMI on baseline study 2, 3
Secondary Mechanism: Resolution of Respiratory-Induced PLMs
In patients with mild OSA, the opposite can occur—PLMI may actually decrease with CPAP 3. This happens when periodic limb movements are triggered by subclinical respiratory events (respiratory effort-related arousals) that resolve with CPAP treatment. However, this is less common than the unmasking phenomenon.
Prevalence and Clinical Significance
- CPAP-emergent PLMS occurs in approximately 8-10% of adult patients 4, 5 and 5.1% of pediatric patients 6
- The phenomenon is not due to CPAP itself but rather reveals a coexisting sleep disorder 1
- PLMS during CPAP titration show high night-to-night variability and occur predominantly in the first 4 hours of sleep 1
Diagnostic Criteria Context
According to the 2025 AASM guidelines, PLMD cannot be diagnosed when other sleep disorders that commonly present with PLMS are present, including untreated OSA 1. The appearance of elevated PLMI during CPAP titration (when OSA is being treated) allows for proper evaluation of whether true PLMD exists.
PLMD Diagnostic Thresholds:
Clinical Implications
The elevated PLMI during titration is clinically significant because:
- PLMs are associated with EEG arousals and invariably cause elevations in heart rate and blood pressure 1
- There is a linear correlation between PLMI and PLM arousal index 2
- This may explain persistent sleep complaints despite adequate CPAP therapy
- In severe cases, additional treatment for RLS/PLMD may be warranted after optimizing CPAP therapy
Common Pitfall to Avoid
Do not assume the CPAP pressure is inadequate or causing the limb movements. The logarithmic relationship between post-CPAP reduction in AHI and change in PLMI demonstrates this is a physiologic unmasking rather than a pressure-related artifact 3. Increasing CPAP pressure beyond what is needed to resolve respiratory events will not reduce the PLMI and may worsen patient tolerance.